期刊文献+

FasL非增殖腺病毒载体的构建及其在肾细胞中的表达

Construction of Replication-defective Adenovirus Vector Containing Human Fas Ligand Gene and Its Expression
原文传递
导出
摘要 目的构建携带FasL的非增殖腺病毒载体,并研究其生物学特性。方法将人FasL全长cDNA克隆到非增殖腺病毒载体pSuCMV中,获得pSuCMVFasL重组子,经293包装细胞包装,获得氨苄青霉素抗性克隆,命名为pSuCMVFasL。体外感染人近端肾小管上皮细胞株HK-2细胞72h后,Western blot检测其在HK-2细胞中的表达。结果获得携带FasL非增殖腺病毒,滴度为7.3×109pfu/ml;Western blot法检测在其感染的HK-2细胞中能检测到重组的蛋白表达。结论将FasL基因导入非增殖腺病毒载体是一种行之有效的基因转染途径,制备的非增殖腺病毒在体外能有效感染HK-2细胞,为进行体内移植免疫耐受的基因治疗研究奠定基础。 Objective To construct replication-defective adenovirus vector containing human FasL and study its biological function. Methods The human Fas ligand complementary DNA was subcloned to the replication-defective adenovirus vector pSuCMV to obtain pSuCMV-FasL recombinant with direct inserting then packed with 293 amphotropic packaging cells,antiAMP clones were acquired and named as pSuCMVFasL. After infecting HK-2 cells with pSuCMV-FasL for 72 h,the expression of FasL was detected by Western blot. Results The titer of virus was 7.3×10^9 pfu/ml.Soluble fusion protein FasL was expressed in HK-2 cells infected with pSuCMVFasL. Conclusion Introduction of FasL gene to replication-defective adenovirus vector is an effevtive way. pSuCMVFasL prepared in this study can efficiently transfer exogenous gene into HK-2 cells.It may be used as a novel immunosuppressive agent for gene therapy in organ transplantation.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2009年第1期62-64,共3页 Suzhou University Journal of Medical Science
关键词 FsaL配体 腺病毒 基因转移 基因表达 fas ligand adenovirus gene transfer gene expression
  • 相关文献

参考文献1

二级参考文献32

  • 1Kai Sun,Zhi-Su Liu,Quan Sun.Role of mitochondria in cell apoptosis during hepatic ischemia-reperfusion injury and protective effect of ischemic postconditioning[J].World Journal of Gastroenterology,2004,10(13):1934-1938. 被引量:86
  • 2Heather HARTIG,Ivan DZHAGALOV,David DRAPER.The role of apoptosis in the development and function of T lymphocytes[J].Cell Research,2005,15(10):749-769. 被引量:16
  • 3Zender L,Hutker S,Liedtke C,et al.Caspase 8 small interfering RNA prevents acute liver failure in mice. Proceedings of the National Academy of Sciences of the United States of America . 2003
  • 4Rodriguez I,Matsuura K,Khatib K,et al.A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. The Journal of Experimental Medicine . 1996
  • 5Arjang Djamali,Kenneth R. Waller,Jonathan McAnulty,Debra Hullett,Bryan N. Becker,Jon S. Odorico.Intrathymic injection of anti-Fas monoclonal antibody prolongs murine non-vascularized cardiac allograft survival[J]. Transplant International . 2004 (6)
  • 6W ang X,DeFrances MC,Dai Y,Pediaditakis P,Johnson C,Bell A, et al.A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Molecular Cell . 2002
  • 7Z ucchini N,,de Sousa G,Bailly-Maitre B,Gugenheim J,Bars R,Lemaire G, et al.Regulation of Bcl-2 and Bcl-xL anti- apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. Biochimica et Biophysica Acta . 2005
  • 8S utton VR,Vaux DL,Trapani JA.Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes. J Immunol . 1997
  • 9Rao JN,Guo X,Liu L,Zou T,Murthy KS,Yuan JX, et al.Polyamines regulate Rho-kinase and myosin phosphorylation during intestinal epithelial restitution. American Journal of Physiology Cell Physiology . 2003
  • 10Z hang X,Brunner T,Carter L,Dutton RW,Rogers P,Bradley L, et al.Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/ FasL-mediated apoptosis. The Journal of Experimental Medicine . 1997

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部